Cosmo Pharmaceuticals NV (LTS:0RGI) YoY EPS Growth : 4,930.00% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Cosmo Pharmaceuticals NV YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Cosmo Pharmaceuticals NV's YoY EPS Growth for the quarter that ended in Jun. 2024 was 4,930.00%.

Cosmo Pharmaceuticals NV's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was CHF4.53.

Cosmo Pharmaceuticals NV YoY EPS Growth Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV YoY EPS Growth Chart

Cosmo Pharmaceuticals NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

-34.56

67.62

326.10

-22.41

-127.92

Cosmo Pharmaceuticals NV Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
YoY EPS Growth	Get a 7-Day Free Trial															211.93	-67.70	-81.56	-166.37	4,930.00

Cosmo Pharmaceuticals NV YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Cosmo Pharmaceuticals NV's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-0.289	-	1.035)	/	\| 1.035 \|
=	-127.92 %

Cosmo Pharmaceuticals NV's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EPS Growth (Q: Jun. 2024 )
=	(Earnings per Share (Diluted) (Q: Jun. 2024 )	-	Earnings per Share (Diluted) (Q: Jun. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Jun. 2023 )) \|
=	(4.527	-	0.09)	/	\| 0.09 \|
=	4,930.00 %

Cosmo Pharmaceuticals NV YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmo Pharmaceuticals NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (LTS:0RGI) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

COPNz:UK C43:Germany COPN:Switzerland

Address

Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2

Website

https://www.cosmopharma.com

Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.

Cosmo Pharmaceuticals NV Headlines

No Headlines